Tuesday, October 19, 2010

On Global Bioenergies, Biochemicals and Bioplastics

By Robin J. Johnson, Ph.D.

Financing agents were undoubtedly pleased when Global Bioenergies of Evry, France, recently announced successful production of isobutene from glucose. The company is using synthetic biology to engineer microorganisms to produce chemicals from biobased sources. Their isobutene technology involves introducing genes that produce enzymes for isobutene biosynthesis. Isobutene has been used in the manufacture of the now-banned gasoline additive, MTBE, and is currently used in the production of isooctane (another fuel additive) and butyl rubber, among other products. The company has exclusive license to technology patented by company cofounder Philippe Marlière.

Alkenes represent an important intermediate in chemical synthesis. The market for polymers of alkenes, such as polyethylene and polypropylene, is enormous. These polymers represent only a portion of chemical applications of alkenes. Today, alkenes are largely produced during petroleum refining processes such as catalytic cracking. (In the petrochemical industry, alkenes are referred to as olefins.) Global Energies' technology allows alkenes to be synthesized from renewable sources such as starch, sugar, or cellulosic materials.

According to a recent Marlière patent, alkenes such as isobutene can be produced by enzymatic decarboxylation of 3-hydroxyalkanoic acids. Certain bacteria produce 3-hydroxyalkanoic acids as building blocks for a type of bioplastic called polyhydroxyalkanoic acids or PHA. The bacteria use PHA for storing energy in much the same way animals use fat. (In fact, the biosynthetic pathway for PHA building blocks is related to metabolic pathways for fatty acids). Bacteria that make PHA can use a wide variety of carbon sources for its synthesis. Marlière’s PCT patent application WO 2010/001078 describes a process where the natural metabolic process for making PHA is subverted for the purpose of making alkenes.

Global Bioenergies is not the only company looking at PHA bioplastics as a source of industrial chemicals. The Massachusetts-based company, Metabolix, is also evaluating PHA as a source of industrial chemicals. In 2007, they received $2 million from the National Institute of Standards and Technology (NIST) to develop a commercially viable process for producing biobased chemicals from renewable agricultural sources. Patent information on Metabolix's technology indicates that the starting material for chemical production is the actual PHA bioplastic itself. That is to say, PHA polymer is treated in various ways to yield several types of industrial chemicals.

No comments:

Post a Comment